Community Hub: Resources for you

Your voice matters notebook

Recent Posts

FDA grants accelerated approval to Tafasitamab-cxix for diffuse large B-cell lymphoma

As of January 2021, the Food and Drug Administration (FDA) has announced the approval of a new medication for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma, who are not eligible for autologous stem cell transplant. The new drug, called Monjuvi (tafasitimab) is a targeted therapy that will be used in combination with lenalidomide (Revlimid). Other combinations are currently under investigation.

Read More »

Let’s Talk About Sex & Cancer Program Summary

Program summary for part 2 of our 4 part Mental Health Series for May 2022.
Program description: Let’s be honest, cancer changes people. Physically and mentally. Sometimes it can be really hard to give yourself permission to find pleasure, feel sexy, and give into intimacy. Learn from a fellow cancer survivor and sex therapist how to find pleasure after a diagnosis and reconnect to your most intimate self. Listening to and exploring your body is the first step in finding pleasure with yourself or with partners.

Read More »
Get The Latest Updates

Subscribe To Our Good Shyt Newsletter

We let you know about the latest resources, virtual events, stories, research opportunities, and more, with an occasional giveaway thrown in for good measure.

Follow us on Social Media

Categories